608 related articles for article (PubMed ID: 18482434)
21. Adolescent exposure to cannabis as a risk factor for psychiatric disorders.
Rubino T; Zamberletti E; Parolaro D
J Psychopharmacol; 2012 Jan; 26(1):177-88. PubMed ID: 21768160
[TBL] [Abstract][Full Text] [Related]
22. [Cannabis and cannabinoid receptors--abuse and psychosis].
Hjorthøj C; Nordentoft M; Fink-Jensen A
Ugeskr Laeger; 2008 Nov; 170(46):3782-4. PubMed ID: 19014732
[TBL] [Abstract][Full Text] [Related]
23. A comparison of the apoptotic effect of Delta(9)-tetrahydrocannabinol in the neonatal and adult rat cerebral cortex.
Downer EJ; Gowran A; Campbell VA
Brain Res; 2007 Oct; 1175():39-47. PubMed ID: 17884022
[TBL] [Abstract][Full Text] [Related]
24. The endocannabinoid system during development: emphasis on perinatal events and delayed effects.
Fride E; Gobshtis N; Dahan H; Weller A; Giuffrida A; Ben-Shabat S
Vitam Horm; 2009; 81():139-58. PubMed ID: 19647111
[TBL] [Abstract][Full Text] [Related]
25. Developmental exposure to cannabinoids causes subtle and enduring neurofunctional alterations.
Campolongo P; Trezza V; Palmery M; Trabace L; Cuomo V
Int Rev Neurobiol; 2009; 85():117-33. PubMed ID: 19607965
[TBL] [Abstract][Full Text] [Related]
26. Neuropsychological deficits in long-term frequent cannabis users.
Accordino M; Hart CL
Neurology; 2006 Nov; 67(10):1902; author reply 1902. PubMed ID: 17130442
[No Abstract] [Full Text] [Related]
27. The addictive potential of cannabis.
Kaymakçalan S
Bull Narc; 1981; 33(2):21-31. PubMed ID: 6272922
[TBL] [Abstract][Full Text] [Related]
28. [Neuropsychopharmacology of delta-9-tetrahydrocannabinol].
Costentin J
Ann Pharm Fr; 2008 Aug; 66(4):219-31. PubMed ID: 18847570
[TBL] [Abstract][Full Text] [Related]
29. Cannabis-induced psychotic-like experiences are predicted by high schizotypy. Confirmation of preliminary results in a large cohort.
Stirling J; Barkus EJ; Nabosi L; Irshad S; Roemer G; Schreudergoidheijt B; Lewis S
Psychopathology; 2008; 41(6):371-8. PubMed ID: 18787359
[TBL] [Abstract][Full Text] [Related]
30. The relationship between non-acute adolescent cannabis use and cognition.
Harvey MA; Sellman JD; Porter RJ; Frampton CM
Drug Alcohol Rev; 2007 May; 26(3):309-19. PubMed ID: 17454021
[TBL] [Abstract][Full Text] [Related]
31. The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs.
Gaetani S; Dipasquale P; Romano A; Righetti L; Cassano T; Piomelli D; Cuomo V
Int Rev Neurobiol; 2009; 85():57-72. PubMed ID: 19607961
[TBL] [Abstract][Full Text] [Related]
32. Neurobiological alterations at adult age triggered by adolescent exposure to cannabinoids.
Realini N; Rubino T; Parolaro D
Pharmacol Res; 2009 Aug; 60(2):132-8. PubMed ID: 19559364
[TBL] [Abstract][Full Text] [Related]
33. [Schizophrenia and cannabis consumption: epidemiology and clinical symptoms].
Jockers-Scherübl MC
Prax Kinderpsychol Kinderpsychiatr; 2006; 55(7):533-43. PubMed ID: 17058779
[TBL] [Abstract][Full Text] [Related]
34. [Induced psychiatric and somatic disorders to cannabis].
Laqueille X; Launay C; Kanit M
Ann Pharm Fr; 2008 Aug; 66(4):245-54. PubMed ID: 18847572
[TBL] [Abstract][Full Text] [Related]
35. Cannabis reinforcement and dependence: role of the cannabinoid CB1 receptor.
Cooper ZD; Haney M
Addict Biol; 2008 Jun; 13(2):188-95. PubMed ID: 18279497
[TBL] [Abstract][Full Text] [Related]
36. Basic neuroanatomy and neuropharmacology of cannabinoids.
Breivogel CS; Sim-Selley LJ
Int Rev Psychiatry; 2009 Apr; 21(2):113-21. PubMed ID: 19367505
[TBL] [Abstract][Full Text] [Related]
37. Psychiatric aspects of cannabis use in adolescents and young adults.
Tunving K
Pediatrician; 1987; 14(1-2):83-91. PubMed ID: 3497393
[TBL] [Abstract][Full Text] [Related]
38. Regional brain abnormalities associated with long-term heavy cannabis use.
Yücel M; Solowij N; Respondek C; Whittle S; Fornito A; Pantelis C; Lubman DI
Arch Gen Psychiatry; 2008 Jun; 65(6):694-701. PubMed ID: 18519827
[TBL] [Abstract][Full Text] [Related]
39. [Residual neuropsychological, structural and functional brain abnormalities after long-term cannabis use].
Weeda MR; Peters BD; De Haan L; Linszen DH
Tijdschr Psychiatr; 2006; 48(3):185-93. PubMed ID: 16956082
[TBL] [Abstract][Full Text] [Related]
40. The endocannabinoid system in critical neurodevelopmental periods: sex differences and neuropsychiatric implications.
Viveros MP; Llorente R; Suarez J; Llorente-Berzal A; López-Gallardo M; de Fonseca FR
J Psychopharmacol; 2012 Jan; 26(1):164-76. PubMed ID: 21669929
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
